L-817818
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C33H36N4O3 |
| Molar mass | 536.676 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
L-817818 is a chemical compound which acts as an agonist at somatostatin receptor 5. It has neuroprotective effects in animal models and modulates insulin release.[1][2][3][4][5]
References
- ^ Rohrer SP, Schaeffer JM (2000). "Identification and characterization of subtype selective somatostatin receptor agonists". Journal of Physiology, Paris. 94 (3–4): 211–215. doi:10.1016/s0928-4257(00)00215-1. PMID 11087999.
- ^ Kiagiadaki F, Savvaki M, Thermos K (January 2010). "Activation of somatostatin receptor (sst 5) protects the rat retina from AMPA-induced neurotoxicity". Neuropharmacology. 58 (1): 297–303. doi:10.1016/j.neuropharm.2009.06.028. PMID 19576912.
- ^ Li Q, Zhang Y, Wu N, Yin N, Sun XH, Wang Z (August 2019). "Activation of somatostatin receptor 5 suppresses T-type Ca2+ channels through NO/cGMP/PKG signaling pathway in rat retinal ganglion cells". Neuroscience Letters. 708 134337. doi:10.1016/j.neulet.2019.134337. PMID 31220522.
- ^ Li Y, Li X, Geng C, Guo Y, Wang C (September 2021). "Somatostatin receptor 5 is critical for protecting intestinal barrier function in vivo and in vitro". Molecular and Cellular Endocrinology. 535 111390. doi:10.1016/j.mce.2021.111390. PMID 34224803.
- ^ Zhang Y, Wu N, Li Q, Hu X, Wang L, Sun JG, et al. (March 2021). "Neuroprotective effect of the somatostatin receptor 5 agonist L-817,818 on retinal ganglion cells in experimental glaucoma". Experimental Eye Research. 204 108449. doi:10.1016/j.exer.2021.108449. PMID 33465395.